Focused Compounding Fund Amends Parks! America Stake

TL;DR

Focused Compounding Fund updated their Parks! America filing, watch for potential moves.

AI Summary

On September 4, 2024, Focused Compounding Fund, LP, along with Geoff Gannon and Andrew Kuhn, filed an amendment to their Schedule 13D for Parks! America, Inc. This filing indicates a change in their beneficial ownership of the company's common stock.

Why It Matters

This amendment signals a potential shift in the ownership structure or strategy of Parks! America, Inc., which could impact its stock performance and future business decisions.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can precede significant corporate actions or shifts in investor sentiment, introducing a degree of uncertainty.

Key Players & Entities

• Focused Compounding Fund, LP (company) — Filer of the Schedule 13D/A
• Geoff Gannon (person) — Associated with Focused Compounding Capital Management, LLC and the filing
• Andrew Kuhn (person) — Associated with Focused Compounding Capital Management, LLC and the filing
• Parks! America, Inc. (company) — Subject company of the filing
• Focused Compounding Capital Management, LLC (company) — Entity associated with the filers

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, Par Value $0.001 per share (Title of Class of Securitie
• $7,886,254 — t, LLC, Geoff Gannon and Andrew Kuhn is $7,886,254, excluding brokerage commissions. Item
• $0.40 — 344,555 Common Shares of the Company at $0.40 per share, for an aggregate purchase pr
• $537,822 — are, for an aggregate purchase price of $537,822. The closing of the purchase pursuant t

Filing Documents

• prka-sc13da_090424.htm (SC 13D/A) — 65KB
• ex99-1.htm (EX-99.1) — 4KB
• stp_01.jpg (GRAPHIC) — 499KB
• stp_02.jpg (GRAPHIC) — 473KB
• stp_03.jpg (GRAPHIC) — 440KB
• stp_04.jpg (GRAPHIC) — 155KB
• stp_05.jpg (GRAPHIC) — 149KB
• 0001999371-24-011577.txt ( ) — 2432KB

of the Schedule 13D is hereby amended and restated as follows

Item 3 of the Schedule 13D is hereby amended and restated as follows: The Common Shares purchased by Focused Compounding Fund, LP were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted. The aggregate purchase price of the 30,454,705 Common Shares beneficially owned by Focused Compounding Fund, LP, Focused Compounding Capital Management, LLC, Geoff Gannon and Andrew Kuhn is $7,886,254, excluding brokerage commissions. Item 4. Purpose of Transaction

of the Schedule 13D

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Focused Compounding Fund, LP entered into a Stock Purchase Agreement, dated September 4, 2024, by and between Focused Compounding Fund, LP and Todd R. White, the Chief Financial Officer of the Company (the “Stock Purchase Agreement”), pursuant to which Focused Compounding Fund, LP purchased 1,344,555 Common Shares of the Company at $0.40 per share, for an aggregate purchase price of $537,822. The closing of the purchase pursuant to the Stock Purchase Agreement occurred on September 5, 2024. Item 5. Interest in Securities of the Issuer

(a)-(c) of the Schedule

Item 5(a)-(c) of the Schedule 13D is hereby amended and restated as provided below: (a) The percentages used in the Schedule 13D are calculated based upon 75,726,851 Common Shares of the Company outstanding as of August 9, 2024, as reported in the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 13, 2024. See rows (11) and (13) of the cover pages to the Schedule 13D for the aggregate number of Common Shares and percentage of Common Shares beneficially owned by each of the reporting persons. The filing of the Schedule 13D shall not be deemed an admission that the reporting persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Company that it or he does not directly own. Each of the reporting persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own. (b) See rows (7) through (10) of the cover pages to the Schedule 13D for the number of Common Shares as to which each reporting person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. (c) Other than the purchase by Focused Compounding Fund, LP of 1,344,555 Common Shares pursuant to the Stock Purchase Agreement as described in Item 4 above, the reporting persons have not entered into any transactions in the Common Shares of the Company during the past sixty days. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

of the Schedule 13D

Item 6 of the Schedule 13D is hereby amended and supplemented as follows: The description of the Stock Purchase Agreement contained in Item 4 above is incorporated herein by reference. Item 7. Material to be Filed as Exhibits Exhibit 99.1 :Stock Purchase Agreement, dated September 4, 2024, by and between Focused Compounding Fund, LP and Todd R. White. SIGNATURE After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: September 6, 2024 FOCUSED COMPOUNDING FUND, LP By: /s/ Andrew Kuhn Name: Title: Andrew Kuhn Managing Member of General Partner FOCUSED COMPOUNDING CAPITAL MANAGEMENT, LLC By: /s/ Andrew Kuhn Name: Title: Andrew Kuhn Managing Member /s/ Geoff Gannon Geoff Gannon /s/ Andrew Kuhn Andrew Kuhn

View Full Filing

View this SC 13D/A filing on SEC EDGAR